Skip to main content
SpringerLink
Log in

Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role ofd-Ala2-d-Leu5-enkephalin (DADL) and dynorphin A(1-13)

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The role of the different opioid receptors was studied in rats trained to discriminate SC injections of 3.0 mg/kg morphine from saline by tests for generalization to graded doses of morphine and receptor-selective peptides administered into the lateral cerebral ventricle. Dose-dependent morphine-like stimulus effects were produced over a wide range of doses (0.001–30 μg), depending upon ligand and animal, by morphine, by themu-selective peptides DAGO[d-Ala2-NMePhe4-Gly(ol)-enkephalin] and FK33824[d-Ala2,NMePhe4-Met(O)5-(ol)-enkephalin], and by thedelta-selective peptide, DADL[d-Ala2,d-Leu5enkephalin]. The order of relative potency of these substances was: FK33824>DAGO>morphine>DADL. In contrast, DPLPE[d-Pen2,l-Pen5)enkephalin], which has much greaterdelta receptor selectivity than does DADL, and dynorphin A(1-13) (0.1–10 μg), akappa-receptor agonist, engendered choice responding appropriate for saline. When 1.0 μg DADL, a dose lacking morphine-like discriminative effects, was administered concurrently with SC morphine, the stimulus effects of morphine were potentiated. Concurrent administration of 10 μg dynorphin A(1-13) and morphine attenuated the stimulus effects of morphine inconsistently. These results support previous findings thatmu-opioid receptors are of primary importance in mediating the morphine-like discriminative effects of opioid peptides. They also suggest that morphine-like discriminative effects can be modulated by other types of opioid receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Browne RG, Fondren B (1978) β-Endorphin and the narcotic cue. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress. Elsevier/North Holland, Amsterdam Oxford New York, pp 137–147

    Google Scholar 

  • Chang K-J, Cuatrecasas P (1979) Multiple opiate receptors: enkephalins and morphine bind to receptors different specificity. J Biol Chem 254:2610–2618

    Google Scholar 

  • Chang K-J, Wei ET, Chang JK (1983) Potent morphiceptin analogs: Structure activity relationships and morphine-like activities. J Pharmacol Exp Ther 227:403–408

    Google Scholar 

  • Chavkin C, James IF, Goldstein A (1982) Dynorphin is a specific endogenous ligand of the k-opioid receptor. Science 215:413–415

    Google Scholar 

  • Chipken RE, Stewart JM, Morris DH, Crowley TJ (1978) Generalization of (D-ala2)-enkephalinamide but not of substance P to the morphine cue. Pharmacol Biochem Behav 9:129–132

    Google Scholar 

  • Colpaert FC, Niemegeers CJE, Janssen PAJ, van Ree JM (1978) Narcotic cueing properties of intraventricularly administered sufentanil, fentanyl, morphine and met-enkephalin. Eur J Pharmacol 47:115–119

    Google Scholar 

  • Corbett AD, Paterson SJ, McKnight AT, Magnan J, Kosterlitz HW (1982) Dynorphin(1-8) and dynorphin(1-9) are ligands for the kappa subtype of opiate receptor. Nature 299:79–81

    Google Scholar 

  • D'Amato R, Holaday JW (1984) Multiple opioid receptors in endotoxic shock: evidence for involvement and μ-interactions in vivo. Proc Natl Acad Sci USA 81:2898–2901

    Google Scholar 

  • Dray A, Nunan L, Wire W (1986) Centrally administered β-endorphin produces prolonged changes in δ-opioid ligand activity in vivo. Eur J Pharmacol 120:359–362

    Google Scholar 

  • Friedman HJ, Jen M-F, Chang JK, Lee NM, Loh HH (1981) Dynorphin: a possible modulatory peptide on morphine or β-endorphin analgesia in mice. Eur J Pharmacol 69:357–360

    Google Scholar 

  • Galligan JJ, Mosberg HI, Hurst R, Hruby VJ, Burks TF (1984) Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administrered opioids. J Pharmacol Exp Ther 229:641–648

    Google Scholar 

  • Garzon J, Jen M-F, Sanchez-Blazquez P, Lee NM (1982) Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro. Life Sci 31:1789–1792

    Google Scholar 

  • Gilbert PE, Martin WR (1976) The effects of morphine- and nalorphine-like drugs in the non-dependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J Pharmacol Exp Ther 198:66–82

    Google Scholar 

  • Goldstein A (1964) Biostatistics: An Introductory Text. MacMillan

  • Handa BK, Lane AC, Lord JAH, Morgan BA, Rance JM, Smith CFC (1981) Analogues of β-LPH61-64 possessing selective agonist activity at μ-opiate receptors. Eur J Pharmacol 70:531–540

    Google Scholar 

  • Herling S, Woods JH (1981) Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. Life Sci 28:1571–1584

    Google Scholar 

  • Herman BH, Leslie F, Goldstein A (1980) Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) andd-Ala2-dynorphin-(1-11) in rats. Life Sci 27:883–892

    Google Scholar 

  • Holtzman SG (1982) Stimulus properties of opioids with mixed agonist and antagonist activity. Fed Proc 41:2328–2332

    Google Scholar 

  • Holtzman SG (1983) Discriminative stimulus properties of opioid agonists and antagonists. In: Cooper SJ (ed) Theory in psychopharmacology, vol. 2. Academic Press, London, pp 1–45

    Google Scholar 

  • James IF, Chavkin C, Goldstein A (1982) Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin. Proc Natl Acad Sci USA 79:7570–7574

    Google Scholar 

  • Lee NM, Landahl H (1986) Dynorphin: specific binding to opiate receptors. In: Brown RM, Clouet DH, Friedman DP (eds) Opiate receptor subtypes and brain function, National Institute on Drug Abuse Research Monograph 71, US Department of Health and Human Services, National Institute on Drug Abuse, DHHS publication number (ADM) 86-1462, US Government Printing Office, pp 19–27

  • Lee NM, Smith AP (1980) A protein lipid model of the opiate receptor. Life Sci 26:1459–1464

    Google Scholar 

  • Lee NM, Smith AP (1984) Possible regulatory function of dynorphin and its clinical implications. TIPS 5:108–110

    Google Scholar 

  • Locke KW, Holtzman SG (1986) Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects. J Pharmacol Exp Ther 238:990–996

    Google Scholar 

  • Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267:495–499

    Google Scholar 

  • Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532

    Google Scholar 

  • Mosberg HI, Hurst R, Hruby VJ, Gee K, Yamamura HI, Galligan JJ, Burks TF (1983) Bis-penicillamine enkephalins possess highly improved specificity towards delta opioid receptors. Proc Natl Acad Sci USA 80:5871–5874

    Google Scholar 

  • Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney

    Google Scholar 

  • Roemer D, Buescher HH, Hill RC, Plexx J, Bauer W, Cordinaux F, Closse A, Hause D, Huguenin R (1977) A synthetic enkephalin analog with prolonged parenteral and oral analgesic activity. Nature 268:547–549

    Google Scholar 

  • Rothman RB, Westfall TC (1982) Allosteric coupling between morphine and enkephalin receptors in vitro. Mol Pharmacol 21:548–557

    Google Scholar 

  • Severs WB, Summy-Long J (1976) The role of angiotensin in thirst. Life Sci 17:1513–1526

    Google Scholar 

  • Shannon HE, Holtzman SG (1976) Evaluation of the discriminative effects of morphine in the rat. J Pharmacol Exp Ther 198:54–65

    Google Scholar 

  • Shannon HE, Holtzman SG (1977) Discriminative effects of morphine administered intracerebrally in the rat. Life Sci 21:585–594

    Google Scholar 

  • Shearman GT, Herz A (1982)d-Ala2,d-Leu5-enkephalin generalizes to a discriminative stimulus produced by fentanyl but not ethylketocyclazocine. Pharmacol Biochem Behav 16:249–252

    Google Scholar 

  • Shearman GT, Schulz R, Schiller PW, Herz A (1985) Generalization tests with intraventricularly applied pro-enkephalin β-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine. Psychopharmacology 85:440–443

    Google Scholar 

  • Tulunay FC, Jen M-F, Chang JK, Loh HH, Lee NM (1981) Possible regulatory role of dynorphin on morphine- and β-endorphin-induced analgesia. J Pharmacol Exp Ther 219:296–298

    Google Scholar 

  • van Ree JM, Smyth DG, Colpaert FC (1979) Dependence creating properties of lipotropin C-fragment (beta-endorphin): evidence for internal control of behavior. Life Sci 24:495–502

    Google Scholar 

  • Vaught JL, Takemori AE (1979) Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J Pharmacol Exp Ther 208:86–90

    Google Scholar 

  • Vaught JL, Rothman RB, Westfall TC (1982) Mu and delta receptors: their role in analgesia and in the differential effects of opioid peptides on analgesia. Life Sci 30:1443–1455

    Google Scholar 

  • Woo SK, Tulnay FC, Loh HH, Lee NM (1983) Effect of dynorphine-(1-13) and related peptides on respiratory rate and morphine-induced respiratory rate depression. Eur J Pharmacol 96:117–122

    Google Scholar 

  • Wood PL (1982) Multiple opiate receptors: support for unique mu, delta and kappa sites. Neuropharmacology 21:487–497

    Google Scholar 

  • Woods JH, Hein DW, Herling S, Young AM, Valentino RJ (1980a) Discriminative and reinforcing effects of some systemically active enkephalin analogues. In: Way EL (ed) Endogenous and exogenous opiate agonists and antagonists. Pergamon Press, Oxford New York, pp 443–446

    Google Scholar 

  • Woods JH, Herling S, Valentino RJ, Hein DW, Coale EH Jr (1980b) Narcotic drug discriminations by rhesus monkeys and pigeons. In: Harris LS (ed) Problems of drug dependence 1979. National Institute on Drug Abuse Research Monograph 27, Department of Health, Education and Welfare Publication No. (ADM) 80-901, US Government Printing Office, Washington, D.C., pp 128–134

    Google Scholar 

  • Woods JH, Herling S, Young AM (1981) Comparison of discriminative and reinforcing stimulus characteristics of morphine-like opioids and two met-enkephalin analogues. Neuropeptides 1:409–419

    Google Scholar 

  • Young AM, Woods JH, Herling S, Hein DW (1983) Comparison of the reinforcing and discriminative stimulus properties of opioids and opioid peptides. In: Smith JE, Lane JD (eds) The neurobiology of opiate reward processes. Elsevier Press, Amsterdam Oxford New York, pp 147–174

    Google Scholar 

Download references

Author information

Author notes

  1. M. Ukai

    Present address: Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, 468, Nagoya, Japan

Authors and Affiliations

  1. Department of Pharmacology, Emory University School of Medicine, 30322, Atlanta, GA, USA

    M. Ukai & S. G. Holtzman

Authors
  1. M. Ukai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. G. Holtzman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ukai, M., Holtzman, S.G. Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role ofd-Ala2-d-Leu5-enkephalin (DADL) and dynorphin A(1-13). Psychopharmacology 94, 32–37 (1988). https://doi.org/10.1007/BF00735877

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00735877

Key words

Search

Navigation